Thursday, March 31, 2022 4:07:10 PM
New York Yankees and Duke Basketball
Recent LGVN News
- Life Science Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 06/21/2024 12:35:00 PM
- Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction • GlobeNewswire Inc. • 06/18/2024 08:48:38 PM
- Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024 • GlobeNewswire Inc. • 06/17/2024 01:00:00 PM
- Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds • GlobeNewswire Inc. • 06/17/2024 12:38:31 PM
- Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ as a Potential Treatment for HLHS, a Rare Pediatric Cardiac Disease • GlobeNewswire Inc. • 06/11/2024 01:00:00 PM
- Longeveron® Announces Contract Development and Manufacturing Business and First Contract • GlobeNewswire Inc. • 06/03/2024 01:00:00 PM
- Longeveron® to Attend BIO International Convention 2024 • GlobeNewswire Inc. • 05/28/2024 12:05:00 PM
- Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- Longeveron Announces Board of Directors Planned Transitions • GlobeNewswire Inc. • 05/10/2024 08:05:00 PM
- Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 05/02/2024 12:03:00 PM
- Longeveron to Present at the Planet MicroCap Showcase • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering • GlobeNewswire Inc. • 04/18/2024 08:05:00 PM
- Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC) • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- Longeveron Announces Closing of $5.2 Million Public Offering • GlobeNewswire Inc. • 04/11/2024 09:17:27 PM
- Longeveron Announces Pricing of $5.25 Million Public Offering • GlobeNewswire Inc. • 04/08/2024 06:15:00 PM
- Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals • GlobeNewswire Inc. • 04/08/2024 12:30:00 PM
- IBN Announces Latest Episode of The Bell2Bell Podcast featuring Wa’el Hashad, CEO of Longeveron Inc. • GlobeNewswire Inc. • 11/14/2023 01:17:00 PM
- IBN Coverage Initiated for Longeveron Inc. • GlobeNewswire Inc. • 09/07/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 09:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:34:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 09:27:03 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM